Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 62019TN0697

Case T-697/19: Action brought on 14 October 2019 – Teva Pharmaceutical Industries v EUIPO (Weniger Migräne. Mehr vom Leben)

OJ C 413, 9.12.2019, p. 61–61 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

9.12.2019   

EN

Official Journal of the European Union

C 413/61


Action brought on 14 October 2019 – Teva Pharmaceutical Industries v EUIPO (Weniger Migräne. Mehr vom Leben)

(Case T-697/19)

(2019/C 413/73)

Language of the case: English

Parties

Applicant: Teva Pharmaceutical Industries Ltd (Jerusalem, Israel) (represented by: J. Bogatz and Y. Stone, lawyers)

Defendant: European Union Intellectual Property Office (EUIPO)

Details of the proceedings before EUIPO

Trade mark at issue: Application for European Union word mark Weniger Migräne. Mehr vom Leben – Application for registration No 17 942 400

Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 12 August 2019 in Case R 779/2019-5

Form of order sought

The applicant claims that the Court should:

annul the contested decision;

order EUIPO to pay the costs incurred by the applicant.

Plea in law

Infringement of Article 7(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.


Top
  翻译: